Finance

Lists
Q1 2027 earnings • released • EPS beat +16.68% • Revenue beat +6.26%
See results
AJANTPHARM:NSE
Ajanta Pharma Ltd
₹3,514.00
+1.41%
(+48.80) 1D
Aug 3, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for AJANTPHARM...
Open
₹3,485.50
High
₹3,540.00
Low
₹3,476.20
Mkt. cap
440.03B
Avg. vol.
136.00K
Volume
119.28K
Dividend
1.51%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 5, 2026
P/E ratio
38.69
52-wk high
₹3,598.80
52-wk low
₹2,329.90
EPS
₹90.83
Shares outstanding
88.45M
No. of employees
10K
Open
₹3,485.50
High
₹3,540.00
Low
₹3,476.20
Mkt. cap
440.03B
Avg. vol.
136.00K
Volume
119.28K
Dividend
1.51%
Quarterly dividend
₹13.25
Ex-dividend date
Aug 5, 2026
P/E ratio
38.69
52-wk high
₹3,598.80
52-wk low
₹2,329.90
EPS
₹90.83
Shares outstanding
88.45M
No. of employees
10K
News stories
From sources across the web
Profile
Ajanta Pharma Limited is an Indian multinational pharmaceutical company. The company operates in India, the United States, and over 30 countries across Africa, Southeast Asia, West Asia, and the CIS. It was established in 1973.. Wikipedia
About Ajanta Pharma Ltd
CEO-
Employees10.4K
Founded1973
Headquarters-
SectorPharmaceutical industry
Websiteajantapharma.com
Last report
Jul 30, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
₹26.72 / ₹22.90
+16.68%beat
Revenue / Est. (INR)
16.26B / 15.30B
+6.26%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
13.54B
13.75B
14.22B
16.26B
Cost of goods sold
3.17B
2.86B
3.05B
3.28B
Cost of revenue
3.17B
2.86B
3.05B
3.28B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.17B
3.31B
3.41B
3.81B
Operating expense
7.11B
7.50B
7.87B
8.88B
Total operating expenses
10.28B
10.36B
10.92B
12.16B
Operating income
3.26B
3.39B
3.30B
4.10B
Other non operating income
197.10M
164.20M
170.60M
204.30M
EBT including unusual items
3.41B
3.59B
3.47B
4.47B
EBT excluding unusual items
3.41B
3.59B
3.47B
4.47B
Income tax expense
806.20M
848.30M
804.10M
1.13B
Effective tax rate
23.66%
23.66%
23.17%
25.20%
Other operating expenses
3.51B
3.76B
4.01B
4.63B
Net income
2.60B
2.74B
2.67B
3.34B
Net profit margin
19.22%
19.91%
18.76%
20.56%
Earnings per share
20.82
21.91
21.34
26.72
Interest and investment income
-
-
-
-
Interest expense
-33.90M
-51.00M
-23.60M
-31.80M
Net interest expenses
-33.90M
-51.00M
-23.60M
-31.80M
Depreciation and amortization charges
429.70M
435.10M
453.70M
445.00M
EBITDA
3.68B
3.70B
3.73B
4.53B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps